Emergent BioSolutions Inc. (LON:0IGA)
London · Delayed Price · Currency is GBP · Price in USD 9.90
+0.26 (2.70%)
At close: Oct 24, 2025
Emergent BioSolutions Market Cap
Emergent BioSolutions has a market cap or net worth of 380.36 million as of October 29, 2025. Its market cap has increased by 8.73% in one year.
Market Cap
380.36M
Enterprise Value
688.11M
Revenue
621.58M
Ranking
n/a
PE Ratio
3.74
Stock Price
9.90
Market Cap Chart
Since November 15, 2006, Emergent BioSolutions's market cap has increased from 169.95M to 380.36M, an increase of 123.80%. That is a compound annual growth rate of 4.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 387.81M | -6.27% |
| Dec 31, 2024 | 413.76M | 323.24% |
| Dec 29, 2023 | 97.76M | -80.01% |
| Dec 30, 2022 | 488.99M | -71.69% |
| Dec 31, 2021 | 1.73B | -50.34% |
| Dec 31, 2020 | 3.48B | 65.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.33B |
| GSK plc | 65.14B |
| Haleon | 31.21B |
| Smith & Nephew | 11.69B |
| ConvaTec Group | 4.97B |
| Hikma Pharmaceuticals | 3.88B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.69B |